Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2011, Article ID 419174, 8 pages
Review Article

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer

Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, CO 80045, USA

Received 29 June 2010; Accepted 3 January 2011

Academic Editor: Manfred P. Wirth

Copyright © 2011 Kristene Myklak and Shandra Wilson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Joanne M. Harrington, Dawn C. Schwenke, Dana R. Epstein, and Donald E. Bailey, “Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer,” Oncology Nursing Forum, vol. 41, no. 1, pp. 21–29, 2013. View at Publisher · View at Google Scholar
  • Jennifer L. Quon, James B. Yu, Pamela R. Soulos, and Cary P. Gross, “The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer,” Journal of Geriatric Oncology, vol. 4, no. 1, pp. 9–18, 2013. View at Publisher · View at Google Scholar
  • Paul M. Levine, Michael J. Garabedian, and Kent Kirshenbaum, “Targeting the Androgen Receptor with Steroid Conjugates,” Journal of Medicinal Chemistry, pp. 140708123537006, 2014. View at Publisher · View at Google Scholar
  • Lei Chang, Peter H. Graham, Jingli Hao, Joseph Bucci, Paul J. Cozzi, John H. Kearsley, and Yong Li, “Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar